AUS
NZ
UK
CA
USA
IND
_09_15_2025_06_09_10_957293.png)
Highlights
- Advent International is assessing options for the Dutch medical supplier Mediq, potentially relaunching its sale.
- Mediq operates across 14 countries, providing pharmaceuticals, medical devices, and healthcare services.
- The company has expanded under Advent’s ownership through multiple acquisitions internationally.
Mediq operates in the healthcare sector, focusing on pharmaceuticals, medical devices, and care services across various markets. Originating as a pharmacists’ buying cooperative, the company has grown significantly, now employing thousands and servicing healthcare centers and patients in multiple regions. Its transition to a private entity in the early part of the previous decade under Advent International marked a strategic shift for the company.
Advent International's Ownership
Advent International acquired Mediq and delisted it from the Amsterdam stock exchange. Since then, the firm has overseen its growth through international acquisitions, expanding Mediq’s operations into additional markets. The acquisitions have included entities like H&R Healthcare Ltd. in the United Kingdom and Puls AS in Norway, showcasing a targeted approach to broadening its market presence.
Potential Sale
The prospect of selling Mediq is being considered as Advent International evaluates its portfolio strategies. Although earlier attempts to divest Mediq occurred, the current market conditions may provide new pathways. The valuation being considered reflects the company’s established presence and its expansive operations. The auction process is reportedly under initial stages of planning, with external advisers being consulted for a strategic approach.
Historical Significance
Founded in the late 19th century, Mediq’s evolution from a pharmacists’ cooperative to a multinational healthcare supplier underscores its adaptability within the medical supply sector. Its operations, spanning pharmaceuticals, devices, and patient care services, reflect a comprehensive model of healthcare delivery. Advent’s stewardship has further bolstered its market position through strategic acquisitions and operational enhancements.
Broader Portfolio Activities
Advent International has an extensive history of managing diverse assets. The firm’s exploration of options for Mediq aligns with its broader strategies in asset management. Parallel considerations include the potential sale of Zentiva, a generic drugmaker, indicating a review of multiple holdings within its healthcare portfolio.
Mediq’s journey through acquisitions, market expansion, and sector leadership highlights its role in the evolving healthcare landscape. Whether through continued ownership or sale, the company’s position within the medical supply sector remains significant.
